STARmed Co.,Ltd

STARmed America, Inc. is the U.S. subsidiary of South Korean medical device manufacturer STARmed Co., Ltd., established in October 2023. Based in Los Angeles, the company specializes in FDA-cleared radiofrequency ablation (RFA) systems and electrodes for minimally invasive treatment of soft tissue conditions. STARmed offers four RFA generator systems and over ten types of electrodes, including the pioneering thyroid-dedicated RF electrode first developed in 2004. Products are designed for percutaneous and endoluminal ablation applications across thyroid, liver, kidney, lung, bone, biliary, pancreatic, and uterine fibroid conditions. The company currently supports over 120 medical facilities across 36 U.S. states and has trained more than 300 physicians. STARmed provides comprehensive program support including hands-on training, clinical case assistance, reimbursement guidance, and marketing support, with 96% physician satisfaction rates.